CUV - banter and discussion, page-28

I don't think we can apply to much respect to the shorts thinking - they were shorting this company mostly before FDA approval and they got that wrong. They were also shorting from 9/3 to 13/3 - took price from $15.82 to $14.81 but it required 0.72% of fake/borrowed shares to do this - that is some 350000 shares sold into a lightly traded stock! Missed opportunity to buyback there and how will they make money on those sales? So the shorters in Clinuvel have got many things wrong not to mention it's debt free, profitable and about to hit the biggest market for EPP and growth. And even if all the buying in CUV yesterday and today was shorts closing out they have still only done a very small fraction of what they must do.